...Yupeng Xu; Min Zhang; Haiyan Wang; Suqin Yu Introduction: The aim of this study was to study the relationships between vessel density (VD) in different retinal vascular plexus and retinal vein occlusion-macular edema (RVO-ME) recurrence using wide-field swept source optical coherence tomography...

... and inflammatory factors in patients with macular edema due to central retinal vein occlusion (CRVO). Methods: In 58 patients with macular edema due to CRVO treated by intravitreal ranibizumab injection (IRI), we retrospectively assessed best-corrected visual acuity (BCVA, assessed as the logarithm of the minimum...

...Min Zhang; Yang Liu; Minlu Song; Yang Yu; Shang Ruan; Kairong Zheng; Fenghua Wang; Xiaodong Sun Purpose: The purpose of the study was to investigate the long-term effect of intravitreal dexamethasone (DEX) implant and anti-vascular endothelial growth factor (VEGF) injection on macular edema (ME...

... in patients with macular edema to evaluate macular toxicity. Results: Ninety two cases (92 eyes) were enrolled, including 44 eyes of males and 48 eyes of females with an average age of 55.35 ± 12.32 years. Univariate analysis showed that the intraoperative use of balanced salt solution containing 1 mg/mL...

...Yurika Takano; Hidetaka Noma; Kanako Yasuda; Tomoe Yamaguchi; Hiroshi Goto; Masahiko Shimura Introduction: To investigate the relationship between retinal blood flow and the presence or absence of macular edema (ME) recurrence after intravitreal ranibizumab injection (IRI) in patients with central...

...Yoshihito Sakanishi; Kazunori Tamaki; Keitaro Mashimo; Toshiro Sakuma; Nobuyuki Ebihara Introduction: The role of vascular endothelial growth factor in macular edema (ME) due to branch retinal vein occlusion (BRVO) by enhancing vascular permeability has been well studied. ME due to BRVO often...

...Jie Rao; Na Wu; Xiaoyong Qu; Yuxiang Hu; Yajun Wu; Yi Cheng; Li Yan; Hui Huang; Siyu Li; Ling Shi; Xiaorong Wu Objective: The aim of this work was to evaluate the association between pretreatment inflammation-based factors and outcomes in patients with macular edema (ME) secondary to retinal vein...

...% women) aged 52–88 years were imaged. Macular edema, either subclinical (SCME) or central-involved macular edema (CIME), was present in 43% of eyes in group 10–20, 41% of eyes in group 35, and 38% of eyes in group 43–47. The inner nuclear layer (INL) was the layer showing higher and most frequent...

...Taneto Tomiyasu; Yoshio Hirano; Norihiro Suzuki; Yuya Esaki; Yusuke Yasuda; Akiyoshi Uemura; Tsutomu Yasukawa; Munenori Yoshida; Yuichiro Ogura Purpose: To study the structural and functional changes of retinal ischemia and investigate their association with macular edema (ME) or microaneurysm (MA...

... ranibizumab injection (IRI) or intravitreal aflibercept injection (IAI) to treat central retinal vein occlusion (CRVO) with macular edema. Methods: In 22 CRVO patients scheduled to receive 3 doses of ranibizumab (11 eyes) or aflibercept (11 eyes) at monthly intervals, aqueous samples were collected...

...Conceição Lobo; Isabel Pires; Dalila Alves; Rajeev Pappuru; Luísa Ribeiro; José Cunha-Vaz Purpose: The aim of this study was to examine the relationship between subclinical diabetic macular edema (SCME) and the development of central-involved macular edema (CIME) in patients with diabetes mellitus...

... with mild nonproliferative DR, for 2 years or until the development of central-involved macular edema (CIME), in 2 centers from different regions of the world. A total of 205 eyes/patients fulfilled the inclusion/exclusion criteria and were included in this study. Ophthalmological examinations, fundus...

...Riccardo Sacconi; Maurizio Battaglia Parodi; Stefano Casati; Rosangela Lattanzio; Giorgio Marchini; Francesco Bandello Purpose: To evaluate the effects of intravitreal dexamethasone (DEX) implants in patients affected by diabetic macular edema (DME) with high best-corrected visual acuity (BCVA...

...Xiaoya Gu; Xiaobing Yu; Shuang Song; Hong Dai Background: The aim of this work was to compare the efficacy of intravitreal dexamethasone implant (Ozurdex) and intravitreal ranibizumab (Lucentis) in the treatment of macular edema (ME) caused by retinal vein occlusion (RVO). Methods: Thirty-two ME...

...Svetlana Jovanović; Tatjana Šarenac Vulović; Filip Radotić; Zorica Tončić; Maja Živković; Nenad Petrović Aim: We aimed to analyze the effects of adjunctive posterior sub-Tenon capsule triamcinolone acetonide injection in the treatment of intermediate uveitis macular edema in multiple sclerosis...

...João Figueira; José Henriques; Miguel Amaro; Vítor Rosas; Dalila Alves; José Cunha-Vaz Purpose: The aim of this study was to assess the effectiveness and safety of ILUVIEN® in patients with chronic diabetic macular edema (DME) who were insufficiently responsive to prior therapies. Methods...

...Ozlem Eski Yucel; Ertugrul Can; Hilal Eser Ozturk; Hakki Birinci; Yuksel Sullu Purpose: The aim of this study was to assess the efficacy of a single intravitreal dexamethasone implant (IDI) over 6 months in eyes with chronic diabetic macular edema (DME) that were resistant to intravitreal...

...; Catarina Neves; Torcato Santos; Luisa Ribeiro; Francesco Bandello; Amparo Navea Tejerina; José Cunha-Vaz; for the EVICR.net Purpose: To characterize the relevance of macular thickness changes in the inner and outer rings in the progression of macular edema in eyes/patients with diabetes type 2. Methods...

...Cláudia Farinha; João Pedro Marques; Elisabete Almeida; Alda Baltar; Ana Rita Santos; Pedro Melo; Miguel Costa; João Figueira; Maria Luz Cachulo; Isabel Pires; Rufino Silva Purpose: To evaluate long-term results and predictors of efficacy in patients with macular edema due to retinal vein occlusion...

...; Frank G. Holz; Sandrina Nunes; Dalila Alves; Catarina Neves; Torcato Santos; Luisa Ribeiro; José Cunha-Vaz; for the EVICR.net Purpose: To identify the retinal layer predominantly affected in eyes with subclinical and clinical macular edema in diabetes type 2. Methods: A cohort of 194 type 2 diabetic...